Elizabeth L. Hougen, EVP, Finance & CFO at IONIS PHARMACEUTICALS INC (IONS), sold 225,220 shares at $72.38 ($16.3M) on 2026-03-16, disclosed to the SEC on 2026-03-18.
Scheduled sale ($16.3M) by EVP, Finance & CFO under a pre-arranged 10b5-1 plan. Pre-set trade — not a discretionary signal on the stock.
Negative factors outweigh the positive ones.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $72.38 | 205,608 | $14.9M | 91.2% |
| 2 | $72.77 | 9,440 | $687K | 4.2% |
| 3 | $73.21 | 10,172 | $745K | 4.6% |
| Total | $72.43 avg | 225,220 | $16.3M | 100% |
| Filing → |
| IONS | SELL | 2025-10-01 | $6.5M | — | Filing → |
| IONS | SELL | 2025-02-03 | $49K | — | Filing → |
| IONS | SELL | 2025-01-17 | $582K | — | Filing → |